Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome
about
Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United StatesDiscretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer TypesSystematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers.Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysisPredictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges.Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization.Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas.Expression of minichromosome maintenance genes in renal cell carcinoma.Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma
P2860
Q28487676-C8B59D6C-1054-44AE-B65F-6A59FCE759DCQ31122277-C5AFEC55-E0D9-4195-B877-2022FFAD724BQ35540073-7986E4ED-7885-4591-B3A2-C973B81B6338Q35810625-0CCE7B89-EAB7-46FC-A931-10DAA460A4E7Q36367103-9F29C175-C61E-4C3D-86C9-33774ACB9F50Q38402997-3A942D93-9BDC-4F85-879B-952FC0AE3D70Q38704070-6C38A198-76BD-4D67-8961-696A2865A11AQ38981597-1F04F32B-1021-44E7-B038-1EE473F6A6F0Q41187419-0F0B5927-8922-4F5D-BDC1-6FE0560BE57AQ47104226-A8801409-0EAC-4C7B-8228-A65E13FC9CB2Q47159187-5C7B6EEE-675D-4C1A-BC67-C6CF0570CB37Q58770461-D70A33D9-93EC-4185-84E8-B7964E26F9EB
P2860
Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Integrative genome-wide expres ...... with different patient outcome
@ast
Integrative genome-wide expres ...... with different patient outcome
@en
Integrative genome-wide expres ...... with different patient outcome
@nl
type
label
Integrative genome-wide expres ...... with different patient outcome
@ast
Integrative genome-wide expres ...... with different patient outcome
@en
Integrative genome-wide expres ...... with different patient outcome
@nl
prefLabel
Integrative genome-wide expres ...... with different patient outcome
@ast
Integrative genome-wide expres ...... with different patient outcome
@en
Integrative genome-wide expres ...... with different patient outcome
@nl
P2093
P2860
P50
P356
P1433
P1476
Integrative genome-wide expres ...... with different patient outcome
@en
P2093
Holger Moch
Nicole Bruni
Oliver Laule
Peter Schraml
Philip Zimmermann
Van-Duc Luu
P2860
P2888
P356
10.1186/1471-2407-12-310
P407
P577
2012-07-23T00:00:00Z
P6179
1007633523